Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Supreme Court Won’t Hear Appeal in Lilly Case
WSJ Online
Tuesday, June 28, 2011 - 8:56am
tags:
Eli Lilly, Supreme Court, Zyprexa
5 Dirt Cheap Biotech Stocks Poised to Triple
Seeking Alpha
Tuesday, June 28, 2011 - 8:53am
tags:
Adventrx, Chelsea Therapeutics, Keryx, Palatin, Rexahn
Achillion raises $61M from stock offering
Yahoo/AP
Tuesday, June 28, 2011 - 8:52am
tags:
stock offering, Achillion
Amgen seeks FDA OK to use Xgeva to prevent, delay prostate cancer spread to bones
Yahoo/AP
Tuesday, June 28, 2011 - 8:49am
tags:
Amgen, Xgeva, prostate cancer
Amgen Sells $3 Billion of Bond to Fund Stock Dividend Payments
Bloomberg
Tuesday, June 28, 2011 - 8:43am
tags:
Amgen, dividends, bonds
Novo Nordisk Likely to Profit From Worldwide Growth in Diabetic Treatments
Seeking Alpha
Tuesday, June 28, 2011 - 8:42am
tags:
diabetes, Novo Nordisk
Shire to Produce More Replagal
Yahoo/Zacks.com
Tuesday, June 28, 2011 - 8:41am
tags:
Shire, Replagal, Sanofi, Fabry's disease
How Does Affymetrix Really Boost Its Returns?
Motley Fool
Monday, June 27, 2011 - 6:00pm
tags:
Affymetrix
Busy Week for FDA Leads to Volatile Action in 5 Pharma Stocks
Seeking Alpha
Monday, June 27, 2011 - 5:58pm
tags:
FDA, Durect Corporation, Pain Therapeutics, Acura Pharmaceuticals, Lannett, Fibrocell Science
J&J to link up product marketing
FT.com
Monday, June 27, 2011 - 5:55pm
tags:
JNJ, marketing
AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
Bloomberg
Monday, June 27, 2011 - 5:53pm
tags:
Brilinta, AstraZeneca, aspirin, Plavix, Sanofi, Bristol-Myers Squibb
Pleasure And Pain For Pfizer
Investopedia
Monday, June 27, 2011 - 5:47pm
tags:
Pfizer, Pain Therapeutics, Durect Corporation, JNJ, Abbott Laboratories, Acura Pharmaceuticals
Biotech Clinical Trials Update for 3 Drug Manufacturers
Seeking Alpha
Monday, June 27, 2011 - 5:44pm
tags:
Pfizer, Cel-Sci, Bristol-Myers Squibb, Eliquis, Multikine
As Ph3 failures spike Big Pharma hits the brakes on R&D spending
Fierce Biotech
Monday, June 27, 2011 - 10:44am
tags:
Big Pharma, R&D
[video] State of Biotech: Human Genome Sciences
CNBC
Monday, June 27, 2011 - 10:42am
tags:
Human Genome Sciences
Zyprexa Suit Appeal Rejected by High Court in Victory for Lilly
Bloomberg
Monday, June 27, 2011 - 10:39am
tags:
Zyprexa, Eli Lilly, schizophrenia
Icagen rockets 130% on Pfizer talks
Marketwatch
Monday, June 27, 2011 - 10:37am
tags:
Icagen, Pfizer, M&A
Life Technologies Ties Up with Pharma Majors
Yahoo/Zacks.com
Monday, June 27, 2011 - 10:36am
tags:
Life Technologies, AstraZeneca, Illumina, JNJ
It May Be Time to Throttle Back on Oncothyreon
Seeking Alpha
Monday, June 27, 2011 - 9:27am
tags:
Oncothyreon, Dendreon, ImmunoCellular, Merck KGaA
Watson Files More ANDAs
Yahoo/Zacks.com
Monday, June 27, 2011 - 9:22am
tags:
ANDAs, Watson Pharmaceuticals, GSK, Novartis, Pfizer, Adovart, nabumetone, Pataday

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.